SD-06

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameSD-06

Drug Alias NameSD-06SD-0006

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionP38 mitogen-activated protein kinase inhibitors

TargetsP38 mitogen-activated protein kinase

Therapy Area/IndicationsArthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsArthritis

ATC CodeN/A